International Journal of Cancer
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors.
145:639-648.
2019
-
Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis
2019
-
Parental occupational exposure to pesticides, animals and organic dust and risk of childhood leukemia and central nervous system tumors: Findings from the International Childhood Cancer Cohort Consortium (I4C)
2019
-
The association between birth order and childhood leukemia may be modified by paternal age and birth weight. Pooled results from the International Childhood Cancer Cohort Consortium (I4C).
144:26-33.
2019
-
The future burden of kidney and bladder cancers preventable by behavior modification in Australia: A pooled cohort study
2019
-
The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study.
145:2383-2394.
2019
-
Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
42:238-250.
2018
-
Dairy product consumption and risk of colorectal cancer in an older Mediterranean population at high cardiovascular risk.
143:1356-1366.
2018
-
Lifetime alcohol intake and risk of non-Hodgkin lymphoma: findings from the Melbourne Collaborative Cohort Study.
142:919-926.
2018
-
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination.
141:2410-2422.
2017
-
Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer.
140:1485-1493.
2017
-
Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia.
139:281-290.
2016
-
Risk factors for metachronous colorectal cancer following a primary colorectal cancer: a prospective cohort study.
139:1081-1090.
2016
-
Comparison of anthropometric measures as predictors of cancer incidence: A pooled collaborative analysis of 11 Australian cohorts.
137:1699-1708.
2015
-
NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.
136:E590-E601.
2015
-
Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens.
135:1842-1851.
2014
-
Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome.
135:887-895.
2014
-
Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.
135:731-741.
2014
-
Brush border myosin Ia inactivation in gastric but not endometrial tumors.
132:1790-1799.
2013
-
Mortality among offspring of women diagnosed with cancer: A population-based cohort study.
132:2432-2438.
2013
-
All-cause cancer mortality over 15 years in multi-ethnic Mauritius: The impact of diabetes and intermediate forms of glucose tolerance.
131:2385-2393.
2012
-
Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis.
130:555-566.
2012
-
A novel histone deacetylase inhibitor augments tamoxifen-mediated attenuation of breast carcinoma growth.
125:483-487.
2009
-
Season of diagnosis has no effect on survival from malignant melanoma.
125:488-490.
2009
-
Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B-Raf.
125:297-307.
2009
-
Targeted therapy of renal cell carcinoma: Synergistic activity of cG250-TNF and IFNg.
125:115-123.
2009
-
The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence.
125:171-180.
2009
-
In vivo andin vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer.
116:226-235.
2005
-
Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines.
110:610-616.
2004
-
Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
98:398-408.
2002
-
Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growthin vivo.
94:645-651.
2001
-
Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines.
87:487-498.
2000
-
Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease.
89:8-13.
2000
-
Changes in the expression of idiotype antigen on murine B-cell lymphoma after hyperthermia alone and in combination with interferon and tumour necrosis factor.
45:500-507.
1990
-
The significance of oncogene amplification in primary breast cancer.
43:270-272.
1989
-
Studies of the invasiveness of the chemically induced mouse sarcoma FS9. I. monoclonal antibodies to a 37,000 dalton membrane glycoprotein inhibit invasion of fibroblastsin vitro.
34:407-414.
1984
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)